arrow
D

Doris M. Ponce

Memorial Sloan Kettering Cancer Center
H指数:32
被引数:6,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

一种用于成人同种异基因造血细胞移植受者的活生物疗法产品:一项部分随机、安慰剂对照的1b期临床试验

2026-11-030
OAAI
Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial

鲁索利替尼外用制剂治疗慢性皮肤移植物抗宿主病:一项单中心、随机、双盲、患者内对照的2期临床试验

2026-09-160
OAAI
HLA-A ∗01:01 Allele Is Associated With Increased Risk of Transplant-Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation

HLA-A*01:01等位基因与MHC匹配的未修饰同种异基因造血干细胞移植后移植相关死亡风险增加相关

2026-09-070
OAAI
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations

TP53突变携带的髓系恶性肿瘤中,移植后干预和慢性移植物抗宿主病对生存的影响

2026-04-120
PRE
Outcomes of terminal complement blockade in adults with high-risk transplant-associated thrombotic microangiopathy: a comparative analysis

高危移植相关血栓性微血管病成人中终末补体阻滞的结局:一项比较分析

2025-11-280
PRE
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort

异基因造血细胞移植在未达完全缓解的急性髓系白血病中的应用:当代队列的结局与预后因素

2025-11-250
OAAI
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

接受异基因造血干细胞移植的非霍奇金淋巴瘤患者与非清髓性预处理相比,强度降低

2024-01-012
OAAI
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
2023-09-1210
OAAI
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
2023-09-091
PRE
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
2023-07-2613
OAAI
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
2023-07-267
OA
HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplant cyclophosphamide improves clinical outcomes for racial and ethnic minority patients with hematologic malignancies
2023-01-011
PRE